The power of deep learning to ligand-based novel drug discovery.

Journal: Expert opinion on drug discovery
Published Date:

Abstract

INTRODUCTION: Deep discriminative and generative neural-network models are becoming an integral part of the modern approach to ligand-based novel drug discovery. The variety of different architectures of neural networks, the methods of their training, and the procedures of generating new molecules require expert knowledge to choose the most suitable approach.

Authors

  • Igor I Baskin
    a Faculty of Physics , M.V. Lomonosov Moscow State University , Moscow , Russia.